ENTO

Entero Therapeutics
ENTO

Overview Fund Trends Analyst Outlook Journalist POV

5 hedge funds and large institutions have $2.8M invested in Entero Therapeutics in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

less ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $
Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$345K

Top Sellers

1
-$283K
2
-$52K
3
-$51K
4
IWM
IHT Wealth Management
Illinois
-$14K
5
UBS Group
UBS Group
Switzerland
-$7K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.03M
2
$714K
3
$357K
4
$283K
5
$259K
6
$53K
7
$44K
8
$43K
9
$11K
10
$5K
11
–